To gain new insights into the use of urinary tumor DNA (utDNA), a promising biomarker in the diagnosis, monitoring, and prognosis of bladder cancer, an international team of researchers conducted a ...
A neurologist shares her thoughts and research about “ecstatic epilepsy” in a wide-ranging conversation on how we perceive ...
Managing perioperative opioid risks, improving detection of peripheral artery disease and surgical management of hard-to-treat gastrointestinal cancers, were among the topics UCSF surgeons, clinicians ...
Thank you for joining call showcasing the Altaviva device, which just secured FDA approval back on September 18. I want to remind everyone that today's event is being recorded, and a replay will be ...
The following health care professionals spoke on the panel: Dr. Jenifer Higgins, Dr. Mackenzie Wahl, Dr. Yi Ying Law, Dr.
Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...
Medpage Today on MSN
First-Line Bladder Cancer Trial Makes the Case for HER2 Screening
The first iteration of HER2-targeted drugs showed limited activity in bladder cancer, but the rise of antibody-drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback